Compare · MITQ vs TMO
MITQ vs TMO
Side-by-side comparison of Moving iMage Technologies Inc. (MITQ) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- MITQ operates in Consumer Discretionary, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $259.44B, about 45734.7x MITQ ($5.7M).
- TMO has been more active in the news (10 items in the past 4 weeks vs 3 for MITQ).
- TMO has more recent analyst coverage (25 ratings vs 0 for MITQ).
- Company
- Moving iMage Technologies Inc.
- Thermo Fisher Scientific Inc
- Price
- -
- -
- Market cap
- $5.7M
- $259.44B
- 1M return
- -
- +0.53%
- 1Y return
- -
- +20.97%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- AMEX
- NYSE
- IPO
- 2021
- News (4w)
- 3
- 10
- Recent ratings
- 0
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest MITQ
- SEC Form 10-Q filed by Moving iMage Technologies Inc.
- Moving iMage Technologies Reports Q1 Net Income of $181,000, or $0.02 per Share, on 9.2% Revenue Increase; Hosts Call Today at 11am ET
- Moving iMage Technologies Hosts First Quarter Fiscal 2027 Conference Call November 13, 2026 at 11am ET
- Syufy Enterprises Selects Moving iMage Technologies For Turnkey Upgrade of 16 Screen Theater Complex in Mountain View, California
- Moving iMage Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 10-K filed by Moving iMage Technologies Inc.
- Cinema Solutions Provider Moving iMage Technologies Progresses Toward Profitability, Trimming FY 2026 Net Loss 69% to ($297K) on Net Sales of $17.3M; Hosts Investor Call Today at 11am ET
- Moving iMage Technologies Reschedules Q4 Call to Monday, September 28th at 11am ET
- SEC Form 4 filed by Chief Financial Officer Bedard Barton John
- SEC Form 3 filed by new insider Bedard Barton John
Latest TMO
- Thermo Fisher Scientific to Participate in UBS 2026 CEO Call Series on November 19, 2026
- Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases
- Thermo Fisher Scientific Announces Quarterly Dividend
- SEC Form SCHEDULE 13G filed by Thermo Fisher Scientific Inc
- Director Sperling Scott M gifted 3,490 shares, decreasing direct ownership by 5% to 65,989 units (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. sold $1,999,960 worth of shares (2,831 units at $706.45) (SEC Form 4)
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Leadership Update
- SEC Form 10-Q filed by Thermo Fisher Scientific Inc
- SEC Form 8-K filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Reports Third Quarter 2026 Results